Trial Profile
A Phase I Prospective, Randomized, Double-blind, Placebo-controlled Study Assessing Inhibition of Serum Thromboxane B2 Levels With PN 400 and Low Dose Aspirin.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Esomeprazole/naproxen (Primary) ; Aspirin
- Indications Ankylosing spondylitis; Musculoskeletal pain; Osteoarthritis; Rheumatoid arthritis; Thrombosis
- Focus Adverse reactions; Pharmacodynamics
- 06 Dec 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Apr 2010 New trial record